Table 2 Correlation of the level of FR isoforms with the histopathological parameters and molecular subtypes of invasive ductal carcinoma.

From: Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer

Parameters

 

Cases

FRα (ng/mg) in Tumor

pa

FRβ (ng/mg) in Tumor

pa

Tumor Size

≤2 cm

6

3.05 ± 1.43

0.491

1.89 ± 0.98

 

2–5 cm

27

3.56 ± 1.60

2.46 ± 0.99

 

> 5 cm

6

3.92 ± 1.24

2.49 ± 0.70

0.46

Lymph Node Status

N0

4

2.93 ± 1.53

0.217

1.72 ± 0.24

 

N1

10

3.07 ± 1.05

1.76 ± 0.83

 

N2

15

3.44 ± 1.62

2.45 ± 0.66

 

N3

10

3.62 ± 1.73

3.15 ± 1.06

0.009

Tumor Grade

GI

10

3.15 ± 1.25

0.152

1.89 ± 0.67

 

GII

15

3.29 ± 1.50

2.33 ± 0.85

 

GIII

14

4.41 ± 1.56

2.94 ± 1.06

0.078

Molecular Subtype

PR/ER+

22

2.92 ± 1.21

0.003

2.16 ± 0.85

 

PR/ER−

17

3.93 ± 1.52

2.64 ± 1.04

0.32

HER2+

7

2.52 ± 0.94

0.031

1.91 ± 0.78

 

HER2−

32

3.76 ± 1.52

2.48 ± 0.97

0.188

  1. P value of less than 0.05 was considered statistically significant.
  2. aBy Kruskal-Wallis test or Mann-Whitney test.